The Mesothelioma Center News – Page 28
-
news
Research & Clinical TrialsA recent study out of the United Kingdom finds patients with relapsed malignant mesothelioma can be treated effectively with single-agent nivolumab, safely improving overall and… -
news
Legislation & LitigationEPA’s Asbestos Risk Evaluation Faces Litigation
The Asbestos Disease Awareness Organization continued its challenge of the U.S. Environmental Protection Agency, filing a petition for review Jan. 26 in… -
news
Research & Clinical TrialsStudy: Mesothelioma Survival Rates Rise with SMART Protocol
Using accelerated high-dose radiation prior to surgery produced an unprecedented 65.9-month median survival for a cohort of pleural mesothelioma patients who were part of a… -
news
Treatment & DoctorsThoracic Chemotherapy May Advance Mesothelioma Treatment
Thoracic surgeon Dr. Marcello Migliore is convinced that adding hyperthermic intrathoracic chemotherapy to aggressive surgery can extend survival significantly for patients with pleural mesothelioma cancer. -
news
Research & Clinical TrialsStatins May Give Boost to Mesothelioma Immunotherapy Drugs
Researchers in Europe may have found the key to making immunotherapy drugs such as Opdivo and Keytruda more effective for a larger percentage of… -
news
Asbestos Exposure & BansEPA Evaluation Finds Asbestos Still An Unreasonable Risk
The U.S. Environmental Protection Agency released Part 1 of its Final Risk Evaluation for Asbestos, reaffirming preliminary findings from March that were roundly criticized… -
news
Asbestos Exposure & BansJudge Rules EPA Must Tighten Asbestos Data Collection
United States District Judge Edward Chen has ordered the Environmental Protection Agency to improve its data collection on the amount of raw asbestos and asbestos… -
news
Asbestos Exposure & BansTop 10 Mesothelioma and Asbestos News Stories of 2020
Growing allegations of asbestos-contaminated talc in various consumer products, coupled with historic approval of a new treatment for pleural mesothelioma, made 2020 a year… -
news
Research & Clinical TrialsStudy: Immunotherapy Vaccine for Mesothelioma Still Promising
The ONCOS-102 immunotherapy vaccine continues its move toward future, first-line standard of care treatment for malignant pleural mesothelioma, based upon the latest study follow-up… -
news
Research & Clinical TrialsLatest T-Cell Clinical Trial Opens for Mesothelioma Patients
Memorial Sloan Kettering Cancer Center in New York City has begun recruiting patients with pleural mesothelioma for its latest — and potentially most…